A Phase II Study of Sorafenib in Patients with Locally Advanced And/or Metastatic (stage IIIB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation

被引：0

作者：

Dingemans, A. M. ^{[1
]}

Mellema, W. W. ^{[2
]}

Groen, H. J. M. ^{[3
]}

van Wijk, A. ^{[2
]}

Burgers, S. ^{[4
]}

Kunst, P. W. A. ^{[5
]}

Thunnissen, F. B. ^{[6
]}

Heideman, D. A. M. ^{[6
]}

Smit, E. F. ^{[2
]}

机构：

[1] Maastricht Univ, Pulm Dis, Med Ctr, Maastricht, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, Pulm Dis, Amsterdam, Netherlands

[3] Univ Med Ctr Groningen, Pulm Dis, NL-9713 AV Groningen, Netherlands

[4] Netherlands Canc Inst, Thorac Oncol, Amsterdam, Netherlands

[5] Univ Amsterdam, Acad Med Ctr, Pulm Dis, NL-1105 AZ Amsterdam, Netherlands

[6] Vrije Univ Amsterdam Med Ctr, Pathol, Amsterdam, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

27LBA

引用

页码：14 / 14

页数：1